Narwhal Capital Management Johnson & Johnson Transaction History

Narwhal Capital Management

$1.09 Billion
Q3 2024

A detailed history of Narwhal Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Narwhal Capital Management holds 97,866 shares of JNJ stock, worth $15 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

97,866

Previous 112,093 12.69%

Holding current value

$15 Million

Previous $16.4 Million 3.19%

% of portfolio

1.45%

Previous 1.57%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$145.48 - $167.38 $2.07 Million - $2.38 Million	-14,227 Reduced 12.69%	97,866 $15.9 Million
Q2 2024 Aug 05, 2024	BUY	$144.38 - $157.78 $681,762 - $745,037	4,722 Added 4.4%	112,093 $16.4 Million
Q1 2024 Apr 26, 2024	BUY	$155.22 - $162.74 $1.23 Million - $1.29 Million	7,904 Added 7.95%	107,371 $17 Million
Q4 2023 Jan 24, 2024	BUY	$145.6 - $158.88 $1.18 Million - $1.29 Million	8,106 Added 8.87%	99,467 $15.6 Million
Q3 2023 Oct 27, 2023	BUY	$155.75 - $174.48 $984,963 - $1.1 Million	6,324 Added 7.44%	91,361 $14.2 Million
Q2 2023 Aug 02, 2023	BUY	$154.35 - $166.11 $1.15 Million - $1.24 Million	7,465 Added 9.62%	85,037 $14.1 Million
Q1 2023 May 01, 2023	SELL	$151.05 - $180.26 $1.39 Million - $1.65 Million	-9,180 Reduced 10.58%	77,572 $12 Million
Q4 2022 Jan 30, 2023	BUY	$160.2 - $179.79 $347,313 - $389,784	2,168 Added 2.56%	86,752 $15.3 Million
Q3 2022 Oct 31, 2022	SELL	$161.33 - $179.52 $210,051 - $233,735	-1,302 Reduced 1.52%	84,584 $13.8 Million
Q2 2022 Aug 01, 2022	SELL	$168.19 - $186.01 $1.15 Million - $1.27 Million	-6,823 Reduced 7.36%	85,886 $15.2 Million
Q1 2022 Apr 26, 2022	SELL	$158.14 - $179.59 $812,207 - $922,374	-5,136 Reduced 5.25%	92,709 $16.4 Million
Q4 2021 Jan 26, 2022	BUY	$155.93 - $173.01 $25,728 - $28,546	165 Added 0.17%	97,845 $16.7 Million
Q3 2021 Oct 22, 2021	BUY	$161.5 - $179.47 $1.25 Million - $1.39 Million	7,722 Added 8.58%	97,680 $15.8 Million
Q2 2021 Jul 29, 2021	BUY	$159.48 - $171.07 $205,091 - $219,996	1,286 Added 1.45%	89,958 $14.8 Million
Q1 2021 Apr 23, 2021	BUY	$153.07 - $170.48 $654,221 - $728,631	4,274 Added 5.06%	88,672 $14.6 Million
Q4 2020 Feb 02, 2021	BUY	$137.11 - $157.38 $1.37 Million - $1.57 Million	9,964 Added 13.39%	84,398 $13.3 Million
Q3 2020 Oct 26, 2020	BUY	$140.38 - $153.83 $135,466 - $148,445	965 Added 1.31%	74,434 $11.1 Million
Q2 2020 Jul 22, 2020	BUY	$128.81 - $155.51 $211,634 - $255,502	1,643 Added 2.29%	73,469 $10.3 Million
Q1 2020 Apr 30, 2020	BUY	$111.14 - $153.99 $1.23 Million - $1.7 Million	11,046 Added 18.17%	71,826 $9.42 Million
Q4 2019 Jan 31, 2020	BUY	$127.5 - $146.44 $566,610 - $650,779	4,444 Added 7.89%	60,780 $8.87 Million
Q3 2019 Oct 31, 2019	BUY	$126.95 - $142.14 $58,777 - $65,810	463 Added 0.83%	56,336 $7.29 Million
Q2 2019 Jul 30, 2019	BUY	$131.15 - $144.24 $1.06 Million - $1.17 Million	8,091 Added 16.93%	55,873 $7.78 Million
Q1 2019 Apr 12, 2019	BUY	$125.72 - $139.79 $994,570 - $1.11 Million	7,911 Added 19.84%	47,782 $6.68 Million
Q4 2018 Jan 15, 2019	BUY	$122.84 - $147.84 $139,423 - $167,798	1,135 Added 2.93%	39,871 $5.15 Million
Q3 2018 Oct 23, 2018	SELL	$121.58 - $142.88 $265,165 - $311,621	-2,181 Reduced 5.33%	38,736 $5.35 Million
Q2 2018 Jul 19, 2018	BUY	$119.4 - $131.76 $120,594 - $133,077	1,010 Added 2.53%	40,917 $4.97 Million
Q1 2018 Apr 17, 2018	BUY	$125.1 - $148.14 $9,507 - $11,258	76 Added 0.19%	39,907 $5.11 Million
Q4 2017 Jan 23, 2018	SELL	$131.22 - $143.62 $357,705 - $391,508	-2,726 Reduced 6.41%	39,831 $5.57 Million
Q3 2017 Oct 17, 2017	BUY	$129.47 - $135.38 $5.51 Million - $5.76 Million	42,557	42,557 $5.53 Million

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.

Account

Narwhal Capital Management Johnson & Johnson Transaction History